Additional file 3: Supplementary Fig. 1. Reprograming efficiency and doubling time of iPSCs, related to Fig. 2. Supplementary Fig. 2. Relationship of OCT3/4 and NANOG expression and donor age, related to Fig. 3
Showing transfection efficiency of PX458 in the Eβ-iPSC2 cells. (a) Phase contrast and fluorescent i...
Figure S3. RT-qPCR analysis of DEGs in PCSCs. (a) and (b), RT-qPCR analysis for validation of DEGs i...
Case studies on deriving iPSCs from clinical and non-clinical populations and using iPSC-tissue cell...
Additional file 1: Supplementary Table S1. qRT-PCR primers used for iPSC characterization
Table S1. List of primary MSC samples. Table S2. List of primers. Table S3. List of antibodies. Figu...
Abstract Background Disease-specific induced pluripotent stem cells (iPSCs) are useful tools for pat...
Table S3. Differential expression analysis of iPS-HPC versus iPS-HPC2.0. (XLSX 11 kb
Showing characterization of hiPSCs reprogrammed from human UC-ECs. A Flow cytometry analysis of UC-E...
Table S2. Parameters used in Eq. (2) for the simplified Oct4-Nanog model. (DOCX 42Â kb
Characterization of iPSC lines. Figure S1. Immunostaining of DIAN iPSCs for pluripotency markers. iP...
Figure S1. showing sequencing results of parental and inserted iPSCs. a Parental iPSCs have the know...
Additional file 3: Figure S3. Characterization of iPSC-derived NPCs from two other iPSC clonal lines...
Figure S1. The characteristics of PCOS patient-derived iPSCs and non-PCOS patient-derived iPSCs. (TI...
Characterization of candidate iPSCs. A complete listing of the protein, genetic, epigenetic, and cel...
is Figure S1 showing cellular characteristics and HPC/HSC reprogramming. A Identification of HPC/HSC...
Showing transfection efficiency of PX458 in the Eβ-iPSC2 cells. (a) Phase contrast and fluorescent i...
Figure S3. RT-qPCR analysis of DEGs in PCSCs. (a) and (b), RT-qPCR analysis for validation of DEGs i...
Case studies on deriving iPSCs from clinical and non-clinical populations and using iPSC-tissue cell...
Additional file 1: Supplementary Table S1. qRT-PCR primers used for iPSC characterization
Table S1. List of primary MSC samples. Table S2. List of primers. Table S3. List of antibodies. Figu...
Abstract Background Disease-specific induced pluripotent stem cells (iPSCs) are useful tools for pat...
Table S3. Differential expression analysis of iPS-HPC versus iPS-HPC2.0. (XLSX 11 kb
Showing characterization of hiPSCs reprogrammed from human UC-ECs. A Flow cytometry analysis of UC-E...
Table S2. Parameters used in Eq. (2) for the simplified Oct4-Nanog model. (DOCX 42Â kb
Characterization of iPSC lines. Figure S1. Immunostaining of DIAN iPSCs for pluripotency markers. iP...
Figure S1. showing sequencing results of parental and inserted iPSCs. a Parental iPSCs have the know...
Additional file 3: Figure S3. Characterization of iPSC-derived NPCs from two other iPSC clonal lines...
Figure S1. The characteristics of PCOS patient-derived iPSCs and non-PCOS patient-derived iPSCs. (TI...
Characterization of candidate iPSCs. A complete listing of the protein, genetic, epigenetic, and cel...
is Figure S1 showing cellular characteristics and HPC/HSC reprogramming. A Identification of HPC/HSC...
Showing transfection efficiency of PX458 in the Eβ-iPSC2 cells. (a) Phase contrast and fluorescent i...
Figure S3. RT-qPCR analysis of DEGs in PCSCs. (a) and (b), RT-qPCR analysis for validation of DEGs i...
Case studies on deriving iPSCs from clinical and non-clinical populations and using iPSC-tissue cell...